ARCHIVES

Proflavine Bioassay Ineffective, NCI Says

This article is from The Cancer Letter archive.

Vol. 03 No. 28 | July 15, 1977

Download PDF Visit The Full Archive

Related Articles

Bross Claims New Figures Show High Radiation Risk

February 23, 1979

Diane Fink Accepts VP Job With ACS

April 3, 1981

NCAB Defends Organ Site Program, But DeVita Still Plan to Discuss It With Cancer Panel

October 17, 1980

In Brief: O’Conor Now Top Prospect If Rauscher Leaves; Flood Gives NCI Increase Of Only $11 Million

May 14, 1976

Sustained-Release Leuprolide Under Study In Phase III Trial.

June 30, 2000

Panel Says NIH Must Devise Means For Early Release Of Trials Data

January 25, 1991